Dr. Anderson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 Euclid Ave
Cleveland Clinic Pediatric Heme/Onc/BMT R3
Cleveland, OH 44195Phone+1 216-308-2706Fax+1 216-444-3577- Is this information wrong?
Summary
- Dr. Peter Anderson is a pediatric hematologist/oncologist in Cleveland, OH and is affiliated with multiple hospitals in the area, including Cleveland Clinic and Cleveland Clinic Children's. He received his medical degree from Icahn School of Medicine at Mount Sinai and has been in practice 36 years. He specializes in pediatric sarcoma oncology and pediatric solid tumor oncology and is experienced in pediatric oncology- solid tumors.
Education & Training
- University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1985 - 1988
- Duke University HospitalResidency, Pediatrics, 1983 - 1985
- Duke University HospitalResidency, Internal Medicine, 1981 - 1983
- Icahn School of Medicine at Mount SinaiClass of 1981
Certifications & Licensure
- CA State Medical License 2024 - 2026
- WI State Medical License 1985 - 2025
- OH State Medical License 2015 - 2025
- MN State Medical License 1985 - 2024
- AZ State Medical License 2002 - 2024
- TX State Medical License 2006 - 2024
- NC State Medical License 2013 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- Join now to see all
Awards, Honors, & Recognition
- Professor Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
- Professor University of Texas MD Anderson CancerCenter, 2005
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
- Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma Start of enrollment: 2008 Jan 01
- Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy Start of enrollment: 2008 May 01
- TK216 in Patients With Relapsed or Refractory Ewing Sarcoma Start of enrollment: 2016 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma.Eashwar Somasundaram, Peter M Anderson, Timothy D Smile, Ahmed Halima, James B Broughman, Chandana A Reddy, Shireen Parsai, Jacob G Scott, Timothy Chan, Shauna Campbel...> ;Scientific Reports. 2023 Nov 7
- Salvage stereotactic body radiation therapy re-irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case report.David S Buchberger, Samantha K Cook, Peter M Anderson, Dale R Shepard, Jamie A Ku, Michael A Fritz, Raj Sindwani, Pablo Recinos, Erin S Murphy, Shlomo A Koyfman> ;Pediatric Blood & Cancer. 2023 Oct 1
- 1 citationsRoutine EWS Fusion Analysis in the Oncology Clinic to Identify Cancer-Specific Peptide Sequence Patterns That Span Breakpoints in Ewing Sarcoma and DSRCT.Peter M Anderson, Zheng Jin Tu, Scott E Kilpatrick, Matteo Trucco, Rabi Hanna, Timothy Chan> ;Cancers. 2023 Mar 6
- Join now to see all
Press Mentions
- 'Always Keep Your Hope': Cleveland Heights Woman Names Son After Oncologist Who Helped Save Her LifeMay 25th, 2022
- Len Rome’s Local Health: Childhood Cancer Patient Finds Hope and Treatment in Northeast OhioOctober 1st, 2020
- Young Girl Is Cancer-Free After Yearlong Battle with Rare SarcomaSeptember 24th, 2020
- Join now to see all
Grant Support
- 153 Sm-Edtmp For Bone Metastases--Phase I Dose Escalation StudyNational Center For Research Resources1998–2002
- IL-2 Liposomes In Cancer Of The LungNational Cancer Institute1991–1995
Professional Memberships
- Member
- ASPHOMember
- SIOPMember
- Member
- CTOSMember
- Member
Hospital Affiliations
- Cleveland ClinicCleveland, Ohio
- Cleveland Clinic Childrens HospitalCleveland, Ohio
Industry Relationships
- Inventor, Healiosglutamine+ disaccharide (trehalose) to reduce mucositis (stomatitis, esophagitis, enteritis)Disclosure: Enlivity Scientific Advisory Board2015 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: